ES498734A0 - Procedimiento para la obtencion de un agente anti-infarto miocardio - Google Patents

Procedimiento para la obtencion de un agente anti-infarto miocardio

Info

Publication number
ES498734A0
ES498734A0 ES498734A ES498734A ES498734A0 ES 498734 A0 ES498734 A0 ES 498734A0 ES 498734 A ES498734 A ES 498734A ES 498734 A ES498734 A ES 498734A ES 498734 A0 ES498734 A0 ES 498734A0
Authority
ES
Spain
Prior art keywords
myocardium
procedure
obtaining
infarction agent
infarction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES498734A
Other languages
English (en)
Spanish (es)
Other versions
ES8201567A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Chemiphar Co Ltd
Original Assignee
Nippon Chemiphar Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co Ltd filed Critical Nippon Chemiphar Co Ltd
Publication of ES8201567A1 publication Critical patent/ES8201567A1/es
Publication of ES498734A0 publication Critical patent/ES498734A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/48—Compounds containing oxirane rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES498734A 1980-01-25 1981-01-22 Procedimiento para la obtencion de un agente anti-infarto miocardio Granted ES498734A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP690780A JPS56104816A (en) 1980-01-25 1980-01-25 Preventive and remedy for caridac infarction

Publications (2)

Publication Number Publication Date
ES8201567A1 ES8201567A1 (es) 1982-01-01
ES498734A0 true ES498734A0 (es) 1982-01-01

Family

ID=11651300

Family Applications (1)

Application Number Title Priority Date Filing Date
ES498734A Granted ES498734A0 (es) 1980-01-25 1981-01-22 Procedimiento para la obtencion de un agente anti-infarto miocardio

Country Status (7)

Country Link
JP (1) JPS56104816A (enrdf_load_stackoverflow)
BR (1) BR8100350A (enrdf_load_stackoverflow)
DE (1) DE3102486A1 (enrdf_load_stackoverflow)
ES (1) ES498734A0 (enrdf_load_stackoverflow)
FR (1) FR2474497A1 (enrdf_load_stackoverflow)
GB (1) GB2067999A (enrdf_load_stackoverflow)
IT (1) IT1141956B (enrdf_load_stackoverflow)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1595168A (en) * 1977-03-03 1981-08-12 Taisho Pharmaceutical Co Ltd Expoxysuccinic acid derivatives

Also Published As

Publication number Publication date
JPS6365644B2 (enrdf_load_stackoverflow) 1988-12-16
IT1141956B (it) 1986-10-08
FR2474497A1 (fr) 1981-07-31
JPS56104816A (en) 1981-08-20
GB2067999A (en) 1981-08-05
ES8201567A1 (es) 1982-01-01
IT8119331A0 (it) 1981-01-26
DE3102486A1 (de) 1981-11-19
BR8100350A (pt) 1981-08-11

Similar Documents

Publication Publication Date Title
ES505138A0 (es) Procedimiento para la obtencion de acidos 7-amino-1-ciclo- propil-4-oxo-1,4-dihidro-naftirin-3-carboxilicos
ES521545A0 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ES506463A0 (es) Procedimiento mejorado para la fabricacion de un dispositivo electrocronico.
ES515084A0 (es) Procedimiento para la obtencion de 2-arilimidazopiridinas.
ES520273A0 (es) Procedimiento para la obtencion de trimetilolpropano.
ES507635A0 (es) Procedimiento para la preparacion de nuevas fenilalcohilaminas .
ES515445A0 (es) Procedimiento para la obtencion de amino-organoaminosilosanos.
ES507523A0 (es) Procedimiento para la obtencion de disulfuros de xantogeno.
ES516842A0 (es) Procedimiento para la obtencion de benzofuranonas.
ES501347A0 (es) Procedimiento para la obtencion de cianguanidina trisusti- tuidas, de efecto fungicida
ES508086A0 (es) Procedimiento para la obtencion de 2-oxidos de 1,2,5-oxadiazol 3,4-bis-sustituidos.
ES518617A0 (es) Procedimiento para la obtencion de p-tercioctil-fenol.
ES510596A0 (es) Procedimiento para la obtencion de 3-alquen-i-il-2,3-dimetil-ciclopropancarboxilatos de 4-fluor-3-fenoxi-bencilo.
ES522323A0 (es) Procedimiento para la obtencion de 2-halogenopropionatos sustituidos.
ES502951A0 (es) Procedimiento para la obtencion de 4-aralquil-1,4-dihidro- pirdinas
ES514480A0 (es) Procedimiento para la obtencion de derivados de diaril-imidazol.
ES513169A0 (es) Procedimiento para la obtencion de nuevos derivados de benzazol.
ES522474A0 (es) Procedimiento para la obtencion de halogenopropargilformamidas.
ES503653A0 (es) Procedimiento para la obtencion de 2,4-dioxa-7,10-metano-espiro s',s-undecanos.
ES498734A0 (es) Procedimiento para la obtencion de un agente anti-infarto miocardio
ES519809A0 (es) Procedimiento para la obtencion de oxazolidin-2-onas.
MX155669A (es) Procedimiento mejorado para la obtencion de omega-lactamas,particularmente caprolactama
ES504844A0 (es) Procedimiento para la obtencion de a-butirolactonas insatu- radas,ab-sustituidas
ES507729A0 (es) Procedimiento para la obtencion de 6(9)-isopropil-9(6)-metil-6,9 etano-2-oxaspiro n4,5n-dec-7-enos de efecto perfumante.
ES517912A0 (es) Procedimiento para la obtencion de 5-diazacicloalquilimidazo-(1,2-c)-(1,3)-benzodiazepinas.